Skip to main content
. 2025 Sep 4;18:4699–4710. doi: 10.2147/IDR.S541192

Table 3.

Clinical Efficacy and Microbiological Clearance Rates

Secondary Outcome, n (%) Total (n = 80) Omadacycline (n = 43) Tigecycline (n = 37) P-value
Clinical efficacy rates 47(58.75%) 31(72.09%) 16(43.24%) 0.012
Microbiological clearance rates 43(53.75%) 25(58.14%) 18(48.65%) 0.501